Prostaglandin E3

Prostaglandin E3

Systematic (IUPAC) name
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-5-oxocyclopentyl]hept-5-enoic acid
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
CAS Number	802-31-3
PubChem	CID 5280937
ChemSpider	4444439
ChEBI	CHEBI:28031
ChEMBL	CHEMBL2074717
Chemical data
Formula	C20H30O5
Molar mass	350.5 g/mol
SMILES CC/C=C\C[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O
InChI InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h3-4,6-7,12-13,15-17,19,21,23H,2,5,8-11,14H2,1H3,(H,24,25)/b6-3-,7-4-,13-12+/t15-,16+,17+,19+/m0/s1 Key:CBOMORHDRONZRN-QLOYDKTKSA-N

Prostaglandin E3 (PGE3) is a naturally formed prostaglandin and is formed via the cyclooxygenase (COX) metabolism of eicosapentaenoic acid.^[1]

See also

• Prostaglandin E1 (PGE1)
• Prostaglandin E2 (PGE2)

References

1. Kulkarni PS, Srinivasan BD (June 1986). "Eicosapentaenoic acid metabolism in human and rabbit anterior uvea". Prostaglandins 31 (6): 1159–64. doi:10.1016/0090-6980(86)90217-0. PMID 3020617.